Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 5 g; disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 150 mg/ml; disodium edetate, quantity: 30 mg/ml - injection, concentrated - excipient ingredients: water for injections - 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, constipation, headache, leg cramps, black stools, oliguria, stupor, convulsions, palsies and coma. chronic lead poisoning causes variable involvement of the central n

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 15 g; disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: ethanol absolute - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 15 g; disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Malta - Kiingereza - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - disodium phosphate, dihydrate, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, potassium chloride - solution for haemofiltration solution for haemodialysis - disodium phosphate dihydrate 0.187 g/l magnesium chloride hexahydrate 3.05 g/l sodium chloride 7.01 g/l sodium hydrogen carbonate 2.12 g/l potassium chloride 0.314 g/l - blood substitutes and perfusion solutions

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - disodium edetate dihydrate 0.1%{relative} - contact lens solution - 0.1 mg/ml - active: disodium edetate dihydrate 0.1%{relative} excipient: borax boric acid hydrochloric acid hypromellose mannitol polidronium chloride purified water sodium chloride sodium hydroxide

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; thiomersal 0.00115% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     thiomersal 0.00115%

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - disodium edetate dihydrate 0.01%; thiomersal 0.004% - contact lens solution - 0.01%/0.004% - active: disodium edetate dihydrate 0.01% thiomersal 0.004%

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - disodium edetate dihydrate 1% - contact lens solution - 1 % - active: disodium edetate dihydrate 1%

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

morgan and hall ltd - disodium edetate dihydrate 0.01%{relative}; poloxamer 1.3%{relative}; thiomersal 0.004%{relative} - contact lens solution - 0.01/1.3/0.004%w/v - active: disodium edetate dihydrate 0.01%{relative} poloxamer 1.3%{relative} thiomersal 0.004%{relative}